← All companies
ALNYLAM PHARMACEUTICALS, INC.
ALNY - CIK 0001178670
Market cap$38.62 B
Rank#396
SEC filings1,651
The table below shows ALNYLAM PHARMACEUTICALS, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.66B | $966.43M | $812.69M | $866.39M | $819.98M | $496.58M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $777.57M | $405.31M | $327.79M | $237.96M | $198.57M | $102.41M |
| Inventory | $82.72M | $78.51M | $89.15M | $128.96M | $86.36M | $75.20M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.